PROCTER & GAMBLE HEALTH | ALBERT DAVID | PROCTER & GAMBLE HEALTH/ ALBERT DAVID |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | 10.3 | 337.1% | View Chart |
P/BV | x | 10.6 | 2.2 | 483.6% | View Chart |
Dividend Yield | % | 2.0 | 0.8 | 266.2% |
PROCTER & GAMBLE HEALTH ALBERT DAVID |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
ALBERT DAVID Mar-23 |
PROCTER & GAMBLE HEALTH/ ALBERT DAVID |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 649 | 827.1% | |
Low | Rs | 3,883 | 485 | 800.0% | |
Sales per share (Unadj.) | Rs | 740.7 | 598.2 | 123.8% | |
Earnings per share (Unadj.) | Rs | 138.2 | 63.4 | 218.2% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 78.3 | 198.1% | |
Dividends per share (Unadj.) | Rs | 95.00 | 9.00 | 1,055.6% | |
Avg Dividend yield | % | 2.1 | 1.6 | 129.4% | |
Book value per share (Unadj.) | Rs | 447.6 | 545.7 | 82.0% | |
Shares outstanding (eoy) | m | 16.60 | 5.71 | 290.7% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 0.9 | 658.9% | |
Avg P/E ratio | x | 33.5 | 8.9 | 373.9% | |
P/CF ratio (eoy) | x | 29.8 | 7.2 | 411.8% | |
Price / Book Value ratio | x | 10.3 | 1.0 | 994.6% | |
Dividend payout | % | 68.7 | 14.2 | 484.0% | |
Avg Mkt Cap | Rs m | 76,761 | 3,236 | 2,371.9% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 811 | 254.3% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 3,416 | 360.0% | |
Other income | Rs m | 184 | 154 | 119.4% | |
Total revenues | Rs m | 12,480 | 3,570 | 349.6% | |
Gross profit | Rs m | 3,247 | 445 | 730.1% | |
Depreciation | Rs m | 281 | 85 | 328.7% | |
Interest | Rs m | 8 | 6 | 131.8% | |
Profit before tax | Rs m | 3,142 | 507 | 619.3% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 146 | 581.9% | |
Profit after tax | Rs m | 2,295 | 362 | 634.3% | |
Gross profit margin | % | 26.4 | 13.0 | 202.8% | |
Effective tax rate | % | 27.0 | 28.7 | 94.0% | |
Net profit margin | % | 18.7 | 10.6 | 176.2% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 3,932 | 297.9% | |
Current liabilities | Rs m | 6,791 | 1,888 | 359.8% | |
Net working cap to sales | % | 40.0 | 59.9 | 66.9% | |
Current ratio | x | 1.7 | 2.1 | 82.8% | |
Inventory Days | Days | 263 | 217 | 121.1% | |
Debtors Days | Days | 343 | 324 | 106.0% | |
Net fixed assets | Rs m | 10,617 | 1,190 | 892.2% | |
Share capital | Rs m | 166 | 57 | 290.9% | |
"Free" reserves | Rs m | 7,265 | 3,059 | 237.5% | |
Net worth | Rs m | 7,431 | 3,116 | 238.5% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 22,330 | 5,122 | 435.9% | |
Interest coverage | x | 409.1 | 87.9 | 465.5% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.6 | 0.7 | 82.6% | |
Return on assets | % | 10.3 | 7.2 | 143.7% | |
Return on equity | % | 30.9 | 11.6 | 266.0% | |
Return on capital | % | 42.4 | 16.5 | 257.4% | |
Exports to sales | % | 0 | 4.6 | 0.0% | |
Imports to sales | % | 13.1 | 9.0 | 145.4% | |
Exports (fob) | Rs m | NA | 156 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 307 | 523.5% | |
Fx inflow | Rs m | 1,465 | 156 | 938.4% | |
Fx outflow | Rs m | 1,605 | 307 | 523.5% | |
Net fx | Rs m | -140 | -151 | 93.1% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 105 | 2,244.4% | |
From Investments | Rs m | -215 | -50 | 430.4% | |
From Financial Activity | Rs m | -985 | -64 | 1,547.8% | |
Net Cashflow | Rs m | 1,160 | -8 | -13,962.7% |
Indian Promoters | % | 0.0 | 62.1 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 2.7 | 753.6% | |
FIIs | % | 6.2 | 1.0 | 636.7% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 37.9 | 127.2% | |
Shareholders | 56,778 | 11,266 | 504.0% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | ALBERT DAVID | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | 1.40% | 0.45% |
1-Month | -1.15% | 11.61% | 2.55% |
1-Year | 0.73% | 99.32% | 56.14% |
3-Year CAGR | -8.76% | 38.28% | 15.22% |
5-Year CAGR | 4.97% | 25.20% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the ALBERT DAVID share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of ALBERT DAVID the stake stands at 62.1%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of ALBERT DAVID.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
ALBERT DAVID paid Rs 9.0, and its dividend payout ratio stood at 14.2%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of ALBERT DAVID.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.